168 related articles for article (PubMed ID: 33171420)
1. AMH assessment five or more years after an initially low AMH level.
Desongnis S; Robin G; Dewailly D; Pigny P; Catteau-Jonard S
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():70-74. PubMed ID: 33171420
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review.
Anderson RA; Cameron D; Clatot F; Demeestere I; Lambertini M; Nelson SM; Peccatori F
Hum Reprod Update; 2022 May; 28(3):417-434. PubMed ID: 35199161
[TBL] [Abstract][Full Text] [Related]
3. Study of Serum Anti-Mullerian Hormone in the Diagnosis of Ovarian Reserve Function in Patients with Premature Ovarian Insufficiency.
Cai Y; Zhang Q; Yu K; Wang Q
Biomed Res Int; 2022; 2022():3878359. PubMed ID: 36277874
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies.
Jiao X; Meng T; Zhai Y; Zhao L; Luo W; Liu P; Qin Y
Front Endocrinol (Lausanne); 2021; 12():601752. PubMed ID: 33815272
[TBL] [Abstract][Full Text] [Related]
5. Very Low Levels of Serum Anti-Müllerian Hormone as a Possible Marker for Follicle Growth in Patients with Primary Ovarian Insufficiency Under Hormone Replacement Therapy.
Kasahara Y; Osuka S; Bayasula ; Nakanishi N; Murase T; Nakamura T; Goto M; Kotani T; Iwase A; Kikkawa F
Reprod Sci; 2021 Jan; 28(1):31-36. PubMed ID: 32737737
[TBL] [Abstract][Full Text] [Related]
6. Menstrual cycle characteristics of young females with occult primary ovarian insufficiency at initial diagnosis and one-year follow-up with serum amh level and antral follicle count.
Guzel Y; Aba YA; Yakin K; Oktem O
PLoS One; 2017; 12(11):e0188334. PubMed ID: 29176793
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.
Nelson SM; Davis SR; Kalantaridou S; Lumsden MA; Panay N; Anderson RA
Hum Reprod Update; 2023 May; 29(3):327-346. PubMed ID: 36651193
[TBL] [Abstract][Full Text] [Related]
8. Mother's age at menopause but not own age at menarche has an impact on ovarian reserve.
Moreau J; Gatimel N; Cohade C; Parinaud J; Léandri R
Gynecol Endocrinol; 2018 Aug; 34(8):664-665. PubMed ID: 29345168
[TBL] [Abstract][Full Text] [Related]
9. Review of clinical indicators, including serum anti-Müllerian hormone levels, for identification of women who should consider egg freezing.
Martyn F; O'Brien YM; Wingfield M
Int J Gynaecol Obstet; 2017 Jul; 138(1):37-41. PubMed ID: 28378324
[TBL] [Abstract][Full Text] [Related]
10. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve.
von Wolff M; Roumet M; Stute P; Liebenthron J
Maturitas; 2020 Apr; 134():34-40. PubMed ID: 32143774
[TBL] [Abstract][Full Text] [Related]
12. The effect of 12-month dehydroepiandrosterone supplementation on the menstrual pattern, ovarian reserve markers, and safety profile in women with premature ovarian insufficiency.
Wong QHY; Yeung TWY; Yung SSF; Ko JKY; Li HWR; Ng EHY
J Assist Reprod Genet; 2018 May; 35(5):857-862. PubMed ID: 29520734
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone deficiency in females with Fanconi anemia.
Sklavos MM; Giri N; Stratton P; Alter BP; Pinto LA
J Clin Endocrinol Metab; 2014 May; 99(5):1608-14. PubMed ID: 24438373
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
Visser JA; Schipper I; Laven JS; Themmen AP
Nat Rev Endocrinol; 2012 Jan; 8(6):331-41. PubMed ID: 22231848
[TBL] [Abstract][Full Text] [Related]
15. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
16. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
[TBL] [Abstract][Full Text] [Related]
17. Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.
Gorkem U; Kucukler FK; Togrul C; Gungor T
Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):464-468. PubMed ID: 28419409
[TBL] [Abstract][Full Text] [Related]
18. Ovarian reserve in premenopausal women with breast cancer.
Zong X; Yu Y; Chen W; Zong W; Yang H; Chen X
Breast; 2022 Aug; 64():143-150. PubMed ID: 35691250
[TBL] [Abstract][Full Text] [Related]
19. Development of a digital anti-Müllerian hormone immunoassay: ultrasensitive, accurate and practical strategy for reduced ovarian reserve monitoring and assessment.
Kuang X; Wei L; Huang Y; Ji M; Tang Y; Wei B; Yang S; Lai D; Xu H
Talanta; 2023 Feb; 253():123970. PubMed ID: 36206626
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-Müllerian hormone as a marker of ovarian reserve after cancer treatment and/or hematopoietic stem cell transplantation in childhood: proposal for a systematic approach to gonadal assessment.
Molinari S; Parissone F; Evasi V; De Lorenzo P; Valsecchi MG; Cesaro S; Fraschini D; Sangalli R; Cacace G; Biondi A; Balduzzi A; Cattoni A
Eur J Endocrinol; 2021 Oct; 185(5):717-728. PubMed ID: 34519276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]